<code id='57CE8382DB'></code><style id='57CE8382DB'></style>
    • <acronym id='57CE8382DB'></acronym>
      <center id='57CE8382DB'><center id='57CE8382DB'><tfoot id='57CE8382DB'></tfoot></center><abbr id='57CE8382DB'><dir id='57CE8382DB'><tfoot id='57CE8382DB'></tfoot><noframes id='57CE8382DB'>

    • <optgroup id='57CE8382DB'><strike id='57CE8382DB'><sup id='57CE8382DB'></sup></strike><code id='57CE8382DB'></code></optgroup>
        1. <b id='57CE8382DB'><label id='57CE8382DB'><select id='57CE8382DB'><dt id='57CE8382DB'><span id='57CE8382DB'></span></dt></select></label></b><u id='57CE8382DB'></u>
          <i id='57CE8382DB'><strike id='57CE8382DB'><tt id='57CE8382DB'><pre id='57CE8382DB'></pre></tt></strike></i>

          entertainment

          entertainment

          author:knowledge    Page View:98364
          Cigna Healthcare's logo on a phone
          Adobe

          CVS Health viewed Amy Bricker as a potential CEO. But she won’t be going to the health care conglomerate anytime soon.

          A federal appeals court has ruled Bricker, a former high-ranking executive at Cigna, cannot jump to CVS because it would violate her noncompete agreement that she signed while at Cigna. The appeals court’s decision backs up what a district court had previously ruled.

          advertisement

          The case is a prominent example of why the health care industry, and corporate America writ large, does not want noncompetes to go away. In April, the Federal Trade Commission approved a nationwide ban on most such agreements, which prevent workers from moving to other jobs, but companies and corporate lobbying groups have already sued to squash the ban.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          State Dept. review finds Biden bears some blame for Afghanistan failures
          State Dept. review finds Biden bears some blame for Afghanistan failures

          3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

          read more
          Medicare drug price negotiation program allowed for now
          Medicare drug price negotiation program allowed for now

          AfederaljudgemadeakeyrulinginalawsuitchallenginganewdrugpricingprogramAdobeWASHINGTON—Afederalcourtj

          read more
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban

          WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

          read more

          Menendez indictment could see pharma lose a key ally

          Sen.BobMenendez(D-N.J.)MichaelM.Santiago/GettyImagesWASHINGTON—WithmountingcallsforembattledSen.BobM